Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.

This has now been shown by a study conducted by Katrin Stücher in the framework of her doctorate at the Department of Sports Medicine of Goethe University Frankfurt.

Exercise as a therapy to complement chemotherapy has a positive effect on muscles, balance and tumour-related fatigue syndrome.

Patients tolerate the therapy better and experience less disease recurrence (relapses) later on.

This has already been substantiated by many studies in the past.

However, these examined patients in the early stages of their illness and did not differentiate between various types of tumour.

The study, a joint initiative of the Department of Sports Medicine headed by Professor Winfried Banzer and of Medical Clinic I together with the Gastrointestinal Centre of Agaplesion Markus Hospital in Frankfurt, both led by Professor Axel Dignass, shows that patients with an advanced gastrointestinal tumour can also profit from exercise therapy.

In accordance with the recommendations of the American College of Sports Medicine, the participants exercised either three times a week for 50 minutes or five times a week for 30 minutes at a pace which they considered to be "slightly strenuous".

If they were unable to manage this, then they were allowed to shorten their training sessions on the basis of a standardised model.

"For some patients, it was difficult to carry out the walking or jogging program in accordance with the recommendations," explains Katrin Stücher. "A frequent obstacle was the weather: either it was too cold, too hot or too wet. But the side effects of the chemotherapy, such as loss of sensation, weakness, exhaustion, infections or severe diarrhoeaa, also often meant that they had to reduce or even discontinue the programme."

For the participants in the study, the complementary exercise therapy proved valuable despite the need for occasional breaks.

Muscle mass improved as did functional properties, such as balance, walking speed and leg strength.

The study also showed first indications that the toxicity of the chemotherapy can be reduced through moderate activity.

This is important because it is especially due to severe toxic effects that patients with gastrointestinal cancer often have to reduce the dose or even discontinue the chemotherapy altogether.

"I go walking every morning. It's good for both my mind and my body and I'm sure it's contributing to my recovery. I think that if you hadn't encouraged me to continue exercising I would probably not have dared to push myself so far physically", reported one of the participants to Katrin Stücher.

"We believe that it will make sense in future to offer patients opportunities for physical exercise during chemotherapy. To eliminate adversities through the weather, exercise rooms could be set up in hospitals. In addition, we should motivate patients to continue with the program after they have taken a break because of side effects", says Professor Winfried Banzer, Head of the Department of Sports Medicine at Goethe University Frankfurt.

Source: Goethe University Frankfurt